RetaAustralia

RetaAustralia, Australian supplier of research peptides

RetaAustralia presents itself as an Australian supplier of high-purity lyophilized peptides intended for advanced clinical research. The company states that it maintains local inventory, submits every batch to independent testing, and dispatches with express shipping Australia-wide. Its catalog is organized around research compounds such as Retatrutide and Tirzepatide, as well as other combined formulations.

The company identifies itself as a wholesaler of research peptides and states that its operation is aimed at laboratories and academic or corporate teams, not end consumers.

Retatrutide: core compound in the catalog

The material describes Retatrutide as an investigational triple hormone receptor agonist. Unlike earlier-generation peptides, it acts on three distinct receptors: GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and GCGR (glucagon receptor).

According to the published information, this synergistic action makes it a compound of interest for studies on metabolic regulation, energy expenditure, and systemic lipid metabolism. The company notes that purity and stability are critical factors for obtaining reproducible results, and that its product is supplied in lyophilized form to preserve the molecular structure during transport.

Indicated research applications

The site mentions two main lines of study for Retatrutide:

• Metabolic homeostasis studies: the scientific literature cited by the company highlights the impact of triple agonists on metabolic pathways, with a focus on the regulation of hepatic glucose production and cellular insulin sensitivity.
• Lipid metabolism and energy expenditure: glucagon receptor activation stimulates lipolysis and increases resting energy expenditure, which positions it as a candidate for studies on metabolic dysfunction.

The company warns that information on dosing in research settings varies depending on the animal model and the receptor being monitored.

Catalog products

The catalog shown includes several references from the Alluvi brand, all with a certificate of analysis available upon request:

• Alluvi Retatrutide 40 mg ×2 (bundle)
• Alluvi Retatrutide 20 mg (R&D)
• Alluvi Retatrutide BPC-157 & TB-500 40 mg
• Alluvi Glow GHK-Cu – BPC-157 & TB-500 70 mg
• Alluvi NAD+ 1000 mg
• Alluvi Tirzepatide 40 mg

The prices published at the time of the analysis ranged from 109.96 to 384.93 AUD depending on the reference.

Quality control and documentation

RetaAustralia states that every batch undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to confirm the sequence, molecular weight, and purity above 99%. The company states that it uses solid-phase peptide synthesis (SPPS) and rigorous purification protocols.

Certificates of analysis are offered to researchers who request them, with the full HPLC and MS report for the corresponding batch. The company also mentions that the vials are lyophilized to ensure long-term stability and that they are compatible with bacteriostatic water.

Shipping, orders, and terms

The company operates with two dispatch points: a main one in Sydney (New South Wales) and a secondary hub in Melbourne (Victoria). It does not offer in-store delivery or warehouse pickup; all orders are shipped.

Shipping is via AusPost Express at a cost of 15.00 AUD, free for orders over 300 AUD. Orders received before 2:00 PM AEST are dispatched the same day. The company states that the store minimum order is 100 AUD and that it offers volume and bulk purchase discounts.

The purchasing process consists of four steps: sending order details via WhatsApp or email, stock verification and invoice issuance, payment confirmation, and receipt of the AusPost Express tracking number.

Customer service and warnings

The support team is based in Australia and provides assistance via WhatsApp and email. Support hours are Monday to Friday, 9:00 AM to 6:00 PM AEST, with an average response time of under 15 minutes. Wholesale inquiries are handled by email.

The company requires buyers to be over 18 and declares that the products are strictly for laboratory research use. The site includes an explicit warning that they are not for human consumption, although in the FAQ section one answer states the opposite; this contradiction appears as is in the analyzed material.

RetaAustralia also publishes a warning about fake suppliers in the Australian market, mentioning sites that claim to operate locally but ship from abroad, social media accounts without verifiable certificates, and tampered certificates of analysis. It recommends checking that the batch numbers on the vials match those on the certificates.